DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
AV-380
1
Unknown
Investigational
Unknown
Unknown
Cachexia
Unknown
AV-380
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ANHYDROVINBLASTINE
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
ANHYDROVINBLASTINE
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
NIKKOMYCIN
1
Small molecule
Investigational
Unknown
Unknown
Coccidioidomycosis
Unknown
NIKKOMYCIN
×
Maximum Phase:
1
First Approval:
None
UNII:
9Z22C3QQCJ
Molecule Type:
Small molecule
Molecular Formula:
C20H25N5O10
Molecular Weight:
495.45
AlogP:
-3.48
PSA:
250.32
HBD:
8.0
HBA:
#RotB:
8.0
Source:
CIPRALISANT MALEATE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Histamine H3 receptor agonist
CIPRALISANT MALEATE
×
Maximum Phase:
1
First Approval:
None
UNII:
7ENI812SZS
Molecule Type:
Small molecule
Molecular Formula:
C18H24N2O4
Molecular Weight:
332.4
AlogP:
3.34
PSA:
28.68
HBD:
1.0
HBA:
#RotB:
2.0
Source:
DOTAMTATE
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
DOTAMTATE
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
C65H91N17O16PbS2
Molecular Weight:
1637.88
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
CAL-263
1
Small molecule
Investigational
Unknown
Unknown
Rhinitis, Allergic, Seasonal
PI3-kinase p110-delta subunit inhibitor
CAL-263
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PHENFORMIN
1
Small molecule
Investigational
Unknown
Unknown
Melanoma; Diabetes Mellitus
Unknown
PHENFORMIN
×
Maximum Phase:
1
First Approval:
None
UNII:
DD5K7529CE
Molecule Type:
Small molecule
Molecular Formula:
C10H15N5
Molecular Weight:
205.26
AlogP:
0.24
PSA:
97.78
HBD:
5.0
HBA:
#RotB:
3.0
Source:
BLXA4
1
Small molecule
Investigational
Unknown
Unknown
Inflammation
Unknown
BLXA4
×
Maximum Phase:
1
First Approval:
None
UNII:
LXE89WJ787
Molecule Type:
Small molecule
Molecular Formula:
C22H32O5
Molecular Weight:
376.49
AlogP:
3.63
PSA:
97.99
HBD:
4.0
HBA:
#RotB:
13.0
Source:
BMS-986178
1
Unknown
Investigational
Unknown
Unknown
Neoplasms
Unknown
BMS-986178
×
Maximum Phase:
1
First Approval:
None
UNII:
P9XVH8H2HF
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SEVITERONEL
1
Small molecule
Investigational
Unknown
Unknown
Breast Neoplasms; Breast Neoplasms, Male; Neoplasms; Prostatic Neoplasms, Castration-Resistant
Unknown
SEVITERONEL
×
Maximum Phase:
1
First Approval:
None
UNII:
8S5OIN36X4
Molecule Type:
Small molecule
Molecular Formula:
C18H17F4N3O3
Molecular Weight:
399.34
AlogP:
4.05
PSA:
80.26
HBD:
2.0
HBA:
#RotB:
7.0
Source:
AZADIRACHTA INDICA
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
AZADIRACHTA INDICA
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
RGB-286638
1
Small molecule
Investigational
Unknown
Unknown
Hematologic Neoplasms
Cyclin-dependent kinase 1 inhibitor
RGB-286638
×
Maximum Phase:
1
First Approval:
None
UNII:
1GAJ98SC2X
Molecule Type:
Small molecule
Molecular Formula:
C29H35N7O4
Molecular Weight:
545.64
AlogP:
2.42
PSA:
115.06
HBD:
3.0
HBA:
#RotB:
8.0
Source:
CP-742,033
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
CP-742,033
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MIRZOTAMAB CLEZUTOCLAX
1
Antibody
Investigational
Unknown
Unknown
Neoplasms
Unknown
MIRZOTAMAB CLEZUTOCLAX
×
Maximum Phase:
1
First Approval:
None
UNII:
TY49T0B03B
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
XL-844
1
Small molecule
Investigational
Unknown
Unknown
Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma; Neoplasms
Serine/threonine-protein kinase Chk1 inhibitor
XL-844
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CYC-065
1
Unknown
Investigational
Unknown
Unknown
Leukemia, Lymphocytic, Chronic, B-Cell; Neoplasms
Unknown
CYC-065
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
NEOSAXITOXIN
1
Small molecule
Investigational
Unknown
Unknown
Pain
Unknown
NEOSAXITOXIN
×
Maximum Phase:
1
First Approval:
None
UNII:
6YRL8BWD9H
Molecule Type:
Small molecule
Molecular Formula:
C10H17N7O5
Molecular Weight:
315.29
AlogP:
-3.54
PSA:
193.75
HBD:
7.0
HBA:
#RotB:
2.0
Source:
SNS-062
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
SNS-062
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
OLAPTESED PEGOL
1
Unknown
Investigational
Unknown
Unknown
Glioblastoma; Pancreatic Neoplasms
Unknown
OLAPTESED PEGOL
×
Maximum Phase:
1
First Approval:
None
UNII:
MTM792B442
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
IRL-1620
1
Protein
Investigational
Unknown
Unknown
Unknown
Unknown
IRL-1620
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BPN-14967
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BPN-14967
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GSK-1795091
1
Unknown
Investigational
Unknown
Unknown
Neoplasms
Unknown
GSK-1795091
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LEXANERSEN
1
Oligonucleotide
Investigational
Unknown
Unknown
Huntington Disease
Unknown
LEXANERSEN
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Oligonucleotide
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TAK-960
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Serine/threonine-protein kinase PLK1 inhibitor
TAK-960
×
Maximum Phase:
1
First Approval:
None
UNII:
3831VFM1ZB
Molecule Type:
Small molecule
Molecular Formula:
C27H34F3N7O3
Molecular Weight:
561.61
AlogP:
3.55
PSA:
102.93
HBD:
2.0
HBA:
#RotB:
6.0
Source:
LOBELINE
1
Small molecule
Investigational
Unknown
Unknown
Amphetamine-Related Disorders; Attention Deficit Disorder with Hyperactivity
Unknown
LOBELINE
×
Maximum Phase:
1
First Approval:
None
UNII:
D0P25S3P81
Molecule Type:
Small molecule
Molecular Formula:
C22H27NO2
Molecular Weight:
337.46
AlogP:
4.24
PSA:
40.54
HBD:
1.0
HBA:
#RotB:
6.0
Source:
GSK-625433
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
GSK-625433
×
Maximum Phase:
1
First Approval:
None
UNII:
2YAD6KT0NT
Molecule Type:
Small molecule
Molecular Formula:
C26H32N4O5S
Molecular Weight:
512.63
AlogP:
4.02
PSA:
106.78
HBD:
1.0
HBA:
#RotB:
8.0
Source:
BMS-936559
1
Unknown
Investigational
Unknown
Unknown
HIV Infections
Unknown
BMS-936559
×
Maximum Phase:
1
First Approval:
None
UNII:
TLZ6R6973Z
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AV-412
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
AV-412
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
RG-7603
1
Small molecule
Investigational
Unknown
Unknown
Lymphoma, Non-Hodgkin
Serine/threonine-protein kinase mTOR inhibitor
RG-7603
×
Maximum Phase:
1
First Approval:
None
UNII:
579255I6O9
Molecule Type:
Small molecule
Molecular Formula:
C24H32N6O3
Molecular Weight:
452.56
AlogP:
2.27
PSA:
91.85
HBD:
2.0
HBA:
#RotB:
5.0
Source:
ASP-4058
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
ASP-4058
×
Maximum Phase:
1
First Approval:
None
UNII:
01J7526K2Q
Molecule Type:
Small molecule
Molecular Formula:
C19H12F6N4O2
Molecular Weight:
442.32
AlogP:
5.63
PSA:
76.83
HBD:
1.0
HBA:
#RotB:
4.0
Source:
TAS-116
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
TAS-116
×
Maximum Phase:
1
First Approval:
None
UNII:
PLO044MUDZ
Molecule Type:
Small molecule
Molecular Formula:
C25H26N8O
Molecular Weight:
454.54
AlogP:
3.79
PSA:
109.44
HBD:
1.0
HBA:
#RotB:
6.0
Source:
INTERFERON ALFA-2B KINOID
1
Protein
Investigational
Unknown
Unknown
Lupus Erythematosus, Systemic
Unknown
INTERFERON ALFA-2B KINOID
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TEMANOGREL
1
Small molecule
Investigational
Unknown
Unknown
Acute Coronary Syndrome
Serotonin 2a (5-HT2a) receptor inverse agonist
TEMANOGREL
×
Maximum Phase:
1
First Approval:
None
UNII:
F42Z27575A
Molecule Type:
Small molecule
Molecular Formula:
C24H28N4O4
Molecular Weight:
436.51
AlogP:
3.06
PSA:
77.85
HBD:
1.0
HBA:
#RotB:
8.0
Source:
GSK2879552
1
Small molecule
Investigational
Unknown
Unknown
Leukemia; Myelodysplastic Syndromes; Small Cell Lung Carcinoma
Unknown
GSK2879552
×
Maximum Phase:
1
First Approval:
None
UNII:
GT77Z6Y09Z
Molecule Type:
Small molecule
Molecular Formula:
C23H28N2O2
Molecular Weight:
364.49
AlogP:
3.74
PSA:
52.57
HBD:
2.0
HBA:
#RotB:
7.0
Source:
LEXATUMUMAB
1
Antibody
Investigational
Unknown
Unknown
Neuroblastoma; Osteosarcoma; Rhabdomyosarcoma; Sarcoma, Ewing
Tumor necrosis factor receptor superfamily member 10B agonist
LEXATUMUMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
967Q0SJD77
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
1
2
…
110
111
112
113
114
115
116
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA